Cytopia Pty, Ltd. Privately-held Australian drug discovery company with a focus on inflammatory diseases such as: Asthma, Rheumatoid Arthritis, Allergic Rhinitis (Hay fever), Food allergy, Inflammatory Bowel Disease, inter alia. Cytopia's first molecular targets are members of the JAK family of protein tyrosine kinases.
KARD Scientific Conducts in vivo efficacy studies to support drug discovery and development. Models include cancer, neurological, inflammation, arthritis and other diseases.